← Leaderboards
Gurkamal S Chatta
University Of Arkansas Med Scis Ltl Rock
$216,909
Attributed
$216,909
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $618.6K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$835,489 · 5
By mechanism
P20$618,580 · 1
R29$209,211 · 1
M01$7,698 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Richard R Drake$9,503,019
- Ronda S Henry-Tillman$10,205,906
- Deborah O Erwin$2,764,006
- Bart Barlogie$10,937,441
- Teresita M Bellido$8,482,287
Others in their field
Top investigators on “Male”
- Myron E Essex · Harvard University (Sch Of Public Hlth)$47,217,905
- Kc Kent Lloyd · University Of California At Davis$33,183,422
- Linda A Teplin · Northwestern University$32,082,912
- Beth Baseler · Leidos Biomedical Research, Inc.$30,337,006
- Edie C Goldsmith · University Of South Carolina At Columbia$30,062,912
- Kevin A. Pelphrey · University Of California Los Angeles$29,809,496
Research focus
MaleProstate NeoplasmsNeoplasm /Cancer ImmunotherapyAutoantigensT LymphocyteWestern BlottingsImmune Tolerance /UnresponsivenessMolecular CloningDisease /Disorder ModelNonhuman Therapy EvaluationProstatitisTissue /Cell CultureAutoimmune DisorderTumor AntigensAutoimmunityLaboratory RatHormone Binding ProteinPatient Oriented ResearchClinical Trial Phase IiHuman SubjectClinical ResearchHuman Therapy EvaluationCaringCaregivers
Grant awards (7)
Integrating Cancer and Aging$618,580
P20 · FY2007 · CA · contact PI
PH II RNDM DBL BLIND CONTRL'D STDY EVAL SFTY AND EFFICACY PROSTVAC-VF/TRICOM$5,663
M01 · FY2005 · RR
Calcitriol+Dexamethasone in Early Recurrent Prostate Ca$1,526
M01 · FY2004 · RR
PH2 Eval. Sfty Effect. ABX-EGF Pts w/ Prostate Cancer$509
M01 · FY2004 · RR
IMMUNOLOGIC THERAPY OF PROSTATE CANCER$56,669
R29 · FY2001 · CA
IMMUNOLOGIC THERAPY OF PROSTATE CANCER$48,320
R29 · FY2001 · CA
IMMUNOLOGIC THERAPY OF PROSTATE CANCER$104,222
R29 · FY2000 · CA